Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Infection and Immunity
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Microbial Immunity and Vaccines

Effect of Low-Dose Antigen Exposure on Development of Immunity to Helicobacter pylori Infection in Mice

Fiona J. Radcliff, Richard L. Ferrero
Fiona J. Radcliff
Unité de Pathogénie Bactérienne des Muqueuses, Institut Pasteur, Paris 75724, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard L. Ferrero
Unité de Pathogénie Bactérienne des Muqueuses, Institut Pasteur, Paris 75724, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/IAI.69.8.5186-5188.2001
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

The effect of low-dose antigen exposure on the development of immunity to Helicobacter pylori infection was studied in outbred mice. Animals that were primed with a subinfectious number ofH. pylori bacteria exhibited significantly lower bacterial loads after challenge with an infectious dose of pathogen (versus controls, P < 0.05).

The vast majority of individuals who are colonized with Helicobacter pylori remain infected despite the development of vigorous immune responses to the bacterium (5). For this reason, it is generally assumed that host immune responses are ineffective in clearing the infection. Nevertheless, studies on H. pylori seroprevalence in humans showed that up to 1.8% of individuals who were initially identified as being H. pylori positive by serology subsequently became negative upon retesting (15, 23, 24). It was suggested that this seroreversion in H. pylori-infected individuals was due to spontaneous elimination of the bacterium by the host (24). In such instances, however, the eradication ofH. pylori as a consequence of antimicrobial treatment for unrelated infections could not be excluded.

The most compelling evidence for spontaneous elimination of H. pylori infection has come from nonhuman primate studies (6, 7). It was shown that certain monkeys developed transient infections after inoculation with H. pylori strains and that, in the early stages of colonization, individual monkeys displayed varying susceptibilities to different H. pylori strains (6, 7).

The type of host T helper (Th) cell phenotype induced during infection largely determines the outcome (protection or pathogenesis) of host immune responses. The Th response phenotype occurring in the host can be influenced by a multitude of factors, including the local cytokine environment and the size of the antigen or inoculum dose (1, 3, 4, 12, 20). In the Leishmania mouse infection model, it was shown that BALB/c mice that were exposed to a low-dose inoculum ofLeishmania major parasites became resistant to infection despite the innate susceptibility of this mouse strain to L. major infection (3). This resistance was accompanied by a switch of the default Th response of BALB/c animals from a T helper 2 (Th2) type towards a dominant Th1 phenotype, thus mimicking the responses that spontaneously occur inLeishmania-resistant C57BL/6 mice (17, 18).

The aim of the present study was to determine whether exposure to a low-dose inoculum of H. pylori might confer immunity to infection in susceptible mice. To ensure diversity of host immune responses, we used an outbred mouse strain which had previously been shown to be highly susceptible to infection with the mouse-adaptedH. pylori SS1 isolate (9, 16). Thus, 6-week-old specific-pathogen-free outbred Swiss mice (Centre d'Elevage R. Janvier, Le-Genest-St-Isle, France) were divided into three groups. Animals either were left untreated (“naive” animals; n = 5 ) or were administered intragastrically a single low-dose inoculum containing 15 CFU of H. pylori SS1 prepared in peptone trypsin broth (n = 19) or broth medium alone (n = 10) . The minimum infectious dose of H. pylori SS1 for Swiss mice was previously determined to be equivalent to 102 CFU (9). One month later,H. pylori serum antibody levels in the mice were determined and compared to those in animals that had received no treatment (10). All animals were immunoglobulin G (IgG) seronegative for H. pylori (results not shown). Based on previous work (9), it was possible to conclude that the primed mice had not become infected with H. pylori. In addition, the serological data confirmed that the animals were free of intestinalHelicobacter spp. and therefore had not previously been exposed to Helicobacter antigens.

Mice primed with a low-dose inoculum (“primed/challenged” group) and those that had received peptone trypsin broth (“naive/challenged” group) were subsequently administered a challenge dose containing 104 CFU of H. pyloriSS1. The animals were sacrificed 2 months postchallenge. Gastric tissue samples taken from the animals were homogenized, and the bacterial loads were determined by quantitative culture as previously described (9). At this time point, primed/challenged mice had significantly reduced gastric H. pylori loads compared to those from the naive/challenged group (4.2 log CFU/g versus 5.5 log CFU/g; Mann-Whitney test, P < 0.05 ; Fig.1). This is a particularly striking result given the outbred genetic background of the animals. Indeed, it has been shown that outbred mice do not respond to low doses of antigen in a genetically restricted manner (8, 22). In addition, 62% (11/19) of the primed/challenged mice had undetectable levels of bacteria in their gastric mucosa following challenge versus 2 out of 10 of the naive/challenged mice (Fisher's exact test, P = 0.11 ). Although not statistically significant, the absence of detectable infection in these mice is worthy of note because other workers have been unable to achieve sterilizing immunity (as defined by culture negativity) against H. pylori infection in mice vaccinated with highly immunogenic H. pyloriantigen-adjuvant preparations (11, 13, 14).

Fig. 1.
  • Open in new tab
  • Download powerpoint
Fig. 1.

H. pylori bacterial loads determined from the gastric biopsies of mice. Control animals (“naive,” squares) were left untreated throughout, while the other groups were given either peptone trypsin broth (“naive/challenged,” circles) or a low-doseH. pylori inoculum (“primed/challenged,” diamonds) prior to challenge with an infectious pathogen dose. Each point corresponds to the mean value for a mouse, determined in duplicate. Horizontal bars represent the geometric means for each group of mice. The sensitivity of detection of the assay is indicated by a dashed horizontal line.

The results of H. pylori-specific serum and gastric antibody determinations were highly predictive of the culture status of the animals (Fig. 2). All culture-positive mice had increased levels of serum (IgG and IgA) and gastric (IgG and IgM) antibodies (Fig. 2A and B). Conversely, only 2 of the 11 culture-negative mice from the primed/challenged group had raised levels of H. pylori-specific serum IgG antibodies, while one of these mice also had increased levels of specific IgG, IgM, and IgA antibodies in its gastric contents (Fig. 2A and B). It is possible that the infection had been suppressed below the level of detection in these two antibody-positive animals. Nevertheless, the data strongly confirmed the absence of H. pylori infection in the majority of culture-negative mice in the primed/challenged group. Thus, despite repeated exposure of the primed/challenged mice toHelicobacter antigens, the animals did not exhibit any significant humoral response. Previous work with different infection models also showed a downregulation of humoral responses following low-dose antigen administration (3, 4, 18, 20). In the Leishmania infection model, this was associated with a switch of the default Th2 response of the host towards a Th1-dominant phenotype (3, 18).

Fig. 2.
  • Open in new tab
  • Download powerpoint
Fig. 2.

Immune responses in mice after H. pylorichallenge. H. pylori-specific serum (A) and gastric (B) IgG, IgM, and IgA antibody levels are shown. The groups of animals are the same as those described in the Fig. 1 legend. Each point corresponds to the mean value for a mouse, determined in triplicate. Individual values were considered to be significantly increased when they were greater than the mean ± 2 SD of readings for the respective antibody classes, determined from the naive group of mice. Horizontal bars represent the means for each group of mice. Mean serum IgG and IgA levels were significantly raised in naive/challenged and prime/challenged groups (versus controls, t test results were as follows: for IgG, P < 0.001 and P = 0.02 ; and for IgA, P = 0.004 and P = 0.02 , respectively), whereas antibody levels were not statistically different between the two challenged groups (P > 0.05) . Mean gastric IgG, IgM, and IgA levels were significantly raised in both challenged groups (versus controls: for IgG, P < 0.001 and P = 0.02 ; for IgM, P = 0.006 and P = 0.04 ; and for IgA, P = 0.02 and P = 0.008 , respectively), but did not differ between them (P > 0.05) . Arrows indicate two culture-negative mice from the primed/challenge group which had significantly raised levels of serum IgG antibodies (A) and one of these animals who also had raised gastric IgG, IgA, and IgM levels (B). (C) Gastric IFN-γ and IL-4 levels were determined directly on saponized extracts of stomach biopsy samples from mice and are expressed as ratios of the relative amounts of each cytokine (in picograms). The horizontal lines in the box plots correspond to the 10, 25, 50, 75, and 90 percentile values for each group of animals. Outlying values are indicated by symbols. P values were determined by the Mann-Whitney test.

To determine the types of Th responses induced following exposure to a low-dose Helicobacter inoculum, cytokine assays were performed on saponized gastric extracts from the animals using a modification of the technique of Bergquist et al. (2). Gamma interferon (IFN-γ) and interleukin-4 (IL-4) levels in gastric tissue samples were assayed by a double sandwich enzyme-linked immunosorbent assay technique (Pharmingen Inc., San Diego, Calif.). Primed/challenged mice were found to have significantly higher gastric IFN-γ/IL-4 ratios than naive animals (Mann-Whitney test, P = 0.001 ), yet the gastric cytokine levels in primed/challenged mice did not differ significantly from those in naive/challenged animals (P = 0.19) . Therefore the shift in the immune responses of primed/challenged mice towards those of a predominantly cell-mediated Th1 phenotype could not per se account for the immunity observed in the animals. This finding would be consistent with the work of several investigators implicating both Th1 and Th2 responses in immune clearance of Helicobacter infection following oral immunization (11, 21). Others, however, reported that Th2-type responses alone were responsible for protection againstHelicobacter infection (19). Clearly, further studies are warranted to better define the type of immune responses associated with immunity to H. pylori infection, particularly those involved in bacterial elimination following infection.

ACKNOWLEDGMENTS

We are grateful to A. Labigne, in whose unit the work was undertaken, for her support. A. Labigne and P. J. Jenks are thanked for critical reading of the manuscript.

Financial support was provided in part by Acambis, Inc. (Cambridge, Mass.) and Aventis Pasteur Vaccins (Lyon, France). F.J.R was the recipient of a “Poste vert” postdoctoral position from the Institut de la Santé et de la Recherche Médicale, sponsored by the Conseil Régional d'Ile-de-France.

Notes

Editor: J. D. Clements

FOOTNOTES

    • Received 26 February 2001.
    • Returned for modification 18 April 2001.
    • Accepted 14 May 2001.
  • Copyright © 2001 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Bancroft A. J.,
    2. Else K. J.,
    3. Grencis R. K.
    Low-level infection with Trichuris muris significantly affects the polarization of the CD4 response.Eur. J. Immunol.24199431133118
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Bergquist C.,
    2. Mattsson-Rydberg A.,
    3. Lönroth H.,
    4. Svennerholm A.-M.
    Development of a new method for the determination of immune responses in the human stomach.J. Immunol. Methods23420005159
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Bretscher P. A.,
    2. Wei G.,
    3. Menon J. N.,
    4. Bielefeldt-Ohmann H.
    Establishment of stable, cell-mediated immunity that makes “susceptible” mice resistant to Leishmania major.Science2571992539542
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Constant S. L.,
    2. Bottomly K.
    Induction of TH1 and TH2 CD4+ T cell responses: the alternative approaches.Annu. Rev. Immunol.151997297322
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Crabtree J. E.
    Mucosal immune responses to Helicobacter pylori.Eur. J. Gastroenterol. Hepatol.5 (Suppl. 2)1993S30S32
    OpenUrl
  6. 6.↵
    1. Dubois A.,
    2. Berg D. E.,
    3. Incecik E. T.,
    4. Fiala N.,
    5. Heman-Ackah L. M.,
    6. Del Valle J.,
    7. Yang M.,
    8. Wirth H.-P.,
    9. Pérez-Pérez G. I.,
    10. Blaser M. J.
    Host specificity of Helicobacter pylori strains and host responses in experimentally challenged nonhuman primates.Gastroenterology11619999096
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    1. Dubois A.,
    2. Berg D. E.,
    3. Incecik E. T.,
    4. Fiala N.,
    5. Heman-Ackah L. M.,
    6. Pérez-Pérez G. I.,
    7. Blaser M. J.
    Transient and persistent experimental infection of nonhuman primates with Helicobacter pylori: implications for human disease.Infect. Immun.64199628852891
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Fayolle C.,
    2. O'Callaghan D.,
    3. Martineau P.,
    4. Charbit A.,
    5. Clément J. M.,
    6. Hofnung M.,
    7. Leclerc C.
    Genetic control of antibody responses induced against an antigen delivered by recombinant attenuated Salmonella typhimurium.Infect. Immun.62199443104319
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Ferrero R. L.,
    2. Thiberge J.-M.,
    3. Huerre M.,
    4. Labigne A.
    Immune responses of specific-pathogen-free mice to chronic Helicobacter pylori (strain SS1) infection.Infect. Immun.66199813491355
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Ferrero R. L.,
    2. Thiberge J.-M.,
    3. Labigne A.
    Local immunoglobulin G antibodies in the stomach may contribute to immunity against Helicobacter infection in mice.Gastroenterology1131997185194
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Guy B.,
    2. Hessler C.,
    3. Fourage S.,
    4. Haensler J.,
    5. Vialon-Lafay E.,
    6. Rokbi B.,
    7. Quentin-Millet M.-J.
    Systemic immunization with urease protects mice against Helicobacter pylori infection.Vaccine161998850856
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Hernandez-Pando R.,
    2. Pavön L.,
    3. Arriaga K.,
    4. Orozco H.,
    5. Madrid-Marina V.,
    6. Rook G.
    Pathogenesis of tuberculosis in mice exposed to low and high doses of an environmental mycobacterial saprophyte before infection.Infect. Immun.65199733173327
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Keenan J.,
    2. Oliaro J.,
    3. Domigan N.,
    4. Potter H.,
    5. Aitken G.,
    6. Allardyce R.,
    7. Roake J.
    Immune response to an 18-kilodalton outer membrane antigen identifies lipoprotein 20 as a Helicobacter pylori vaccine candidate.Infect. Immun.68200033373343
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Kleanthous H.,
    2. Myers G. A.,
    3. Georgakopoulos K. M.,
    4. Tibbitts T. J.,
    5. Ingrassia J. W.,
    6. Gray H. L.,
    7. Ding R.,
    8. Zhang Z.-Z.,
    9. Lei W.,
    10. Nichols R.,
    11. Lee C. K.,
    12. Ermak T. H.,
    13. Monath T. P.
    Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection.Infect. Immun.66199828792886
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Kumagai T.,
    2. Malaty H. M.,
    3. Graham D. Y.,
    4. Hosogaya S.,
    5. Misawa K.,
    6. Furihata K.,
    7. Ota H.,
    8. Sei C.,
    9. Tanaka E.,
    10. Akamatsu T.,
    11. Shimizu T.,
    12. Kiyosawa K.,
    13. Katsuyama T.
    Acquisition versus loss of Helicobacter pylori infection in Japan: results from an 8-year birth cohort study.J. Infect. Dis.1781998717721
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Lee A.,
    2. O'Rourke J.,
    3. De Ungria M. C.,
    4. Robertson B.,
    5. Daskalopoulos G.,
    6. Dixon M. F.
    A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain.Gastroenterology112199713861397
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Menon J. N.,
    2. Bretscher P. A.
    Characterization of the immunological memory state generated in mice susceptible to Leishmania major following exposure to low doses of L. major and resulting in resistance to a normally pathogenic challenge.Eur. J. Immunol.261996243249
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Menon J. N.,
    2. Bretscher P. A.
    Parasite dose determines the Th1/Th2 nature of the response to Leishmania major independently of infection route and strain of host or parasite.Eur. J. Immunol.28199840204028
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    1. Mohammadi M.,
    2. Nedrud J.,
    3. Redline R.,
    4. Lycke N.,
    5. Czinn S.
    Murine CD4 T-cell response to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load.Gastroenterology113199718481857
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    1. Power C. A.,
    2. Wei G.,
    3. Bretscher P. A.
    Mycobacterial dose defines the Th1/Th2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous, or intradermal route.Infect. Immun.66199857435750
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Radcliff F. J.,
    2. Ramsay A. J.,
    3. Lee A.
    A mixed Th1/Th2 response may be necessary for effective immunity against Helicobacter.Immun. Cell. Biol.S11997A90
    OpenUrl
  22. 22.↵
    1. Vaz N. M.,
    2. Levine B. B.
    Immune responses of inbred mice to repeated low doses of antigen: relationship to histocompatibility (H-2) type.Science1681970852854
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Veldhuyzen van Zanten S. J. O.,
    2. Pollak P. T.,
    3. Best L. M.,
    4. Bezanson G. S.,
    5. Marrie T.
    Increasing prevalence of Helicobacter pylori infection with age: continuous risk of infection in adults rather than cohort effect.J. Infect. Dis.1691994434437
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Xia H. H.,
    2. Talley N. J.
    Natural acquisition and spontaneous elimination of Helicobacter pylori infection: clinical implications.Am. J. Gastroenterol.92199717801787
    OpenUrlPubMedWeb of Science
PreviousNext
Back to top
Download PDF
Citation Tools
Effect of Low-Dose Antigen Exposure on Development of Immunity to Helicobacter pylori Infection in Mice
Fiona J. Radcliff, Richard L. Ferrero
Infection and Immunity Aug 2001, 69 (8) 5186-5188; DOI: 10.1128/IAI.69.8.5186-5188.2001

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Infection and Immunity article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Effect of Low-Dose Antigen Exposure on Development of Immunity to Helicobacter pylori Infection in Mice
(Your Name) has forwarded a page to you from Infection and Immunity
(Your Name) thought you would be interested in this article in Infection and Immunity.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Effect of Low-Dose Antigen Exposure on Development of Immunity to Helicobacter pylori Infection in Mice
Fiona J. Radcliff, Richard L. Ferrero
Infection and Immunity Aug 2001, 69 (8) 5186-5188; DOI: 10.1128/IAI.69.8.5186-5188.2001
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • Notes
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Antigens, Bacterial
Bacterial Proteins
Helicobacter Infections
Helicobacter pylori

Related Articles

Cited By...

About

  • About IAI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #IAIjournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0019-9567; Online ISSN: 1098-5522